Diagnostic Pathology · 2015 · 23 citations · 21 references
MedicineHematologyPathologyHematopathologyHistopathologySystemic PathologyBone Marrow PathologyCoagulation DisordersThromboembolic DiseaseThrombosisThrombotic DisordersHistologic ExaminationHistologic GradeThrombotic Risk AssessmentThrombotic Risk Stratification
BACKGROUND: Vascular events represent the most frequent complications of thrombocytemias. We aimed to evaluate their risk in the WHO histologic categories of Essential Thrombocytemia (ET) and early Primary Myelofibrosis (PMF). METHODS: From our clinical database of 283 thrombocytemic patients, we selected those with available bone marrow histology performed before any treatment, at or within 1 year from diagnosis, and reclassified the 131 cases as true ET or early PMF, with or without fibrosis, according to the WHO histological criteria. Vaso-occlusive events at diagnosis and in the follow-up were compared in the WHO-groups. RESULTS: Histologic review reclassified 61 cases as ET and 72 cases as early PMF (26 prefibrotic and 42 with grade 1 or 2 fibrosis). Compared to ET, early PMF showed a significant higher rate of thrombosis both in the past history (22% vs 8%) and at diagnosis (15.2% vs 1.6%), and an increased leukocyte count (8389 vs 7500/mmc). Venous thromboses (mainly atypical) were relatively more common in PMF than in ET. Patients with prefibrotic PMF, although younger, showed a significant higher 15-year risk of developing thrombosis (48% vs 16% in fibrotic PMF and 17% in ET). At multivariate analysis, age and WHO histology were both independent risk-factors for thrombosis during follow-up; patients >60 yr-old or with prefibrotic PMF showed a significantly higher risk at 20 years than patients <60 yr-old with ET or fibrotic PMF (47% vs 4%, p = 0.005). CONCLUSIONS: Our study support the importance of WHO histologic categories in the thrombotic risk stratification of patients with thrombocytemias. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2020211863144412 .
21
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Jürgen Thiele, Hans Michael Kvasnicka, Fabio Facchetti et al. · PubMed · 2005 · 770 citations
Medicine, Pathology, Hematopathology +15
Tiziano Barbui, Jüergen Thiele, Francesco Passamonti et al. · Journal of Clinical Oncology · 2011 · 538 citations · Full text
Medicine, Hematology, Pathology +17
Hans Carl Hasselbalch · Blood · 2012 · 322 citations